-
FDA Approves Wainua, a Breakthrough Treatment for Rare Genetic Disease-Related Polyneuropathy
Ionis Pharmaceuticals and AstraZeneca have received approval from the U.S. Food and Drug Administration (FDA) for their revolutionary drug,
2023-12-22 16:11 -
Breakthrough Collaboration: Johnson Pharmaceuticals and GSK Join Forces to Advance ADC Therapy HS-20...
Johnson Pharmaceuticals Group Limited and GlaxoSmithKline (LSE/NYSE: GSK) have announced a groundbreaking collaboration, signing an exclusive licensin...
2023-12-21 15:59 -
Gilead Sciences: Expanding Horizons through Strategic Collaborations and Acquisitions
Gilead Sciences, a leading biopharmaceutical company, has been making significant strides in expanding its portfolio and advancing innovative therapie...
2023-12-21 15:50 -
Pharmaceutical Giants with Potential to Join the Trillion-Dollar Club
In the ever-evolving landscape of the pharmaceutical industry, several key players have emerged as potential contenders for the prestigious trillion-d...
2023-12-21 15:44 -
Illumina's Growth Challenges: A Rollercoaster Ride with Grail
Illumina, established in 1998, has long been regarded as a dominant player in the global genomics sequencing field. However, recent years have seen it...
2023-12-21 15:38 -
Pharmaceutical Giants' Strategic Acquisitions: Fueling Innovation and Conquering New Frontiers
In the dynamic landscape of the pharmaceutical industry, strategic acquisitions play a pivotal role in fueling innovation, expanding market presence, ...
2023-12-20 14:02 -
IntegraLifesciences Acquires Acclarent from Johnson & Johnson: A Strategic Move in the ENT Market
In a recent announcement on December 13, 2023, IntegraLifesciences, a leading organization in tissue repair, revealed its agreement to acquire Acclare...
2023-12-20 13:53 -
Strategic Site Selection for Biopharmaceutical Companies at Different Development Stages
The biopharmaceutical industry in China encompasses various fields of development, each at different stages of maturity.
2023-12-20 13:50 -
The Current Status and Trends in the Biopharmaceutical Industry: Insights and Outlook
The biopharmaceutical industry is a rapidly evolving sector driven by advancements in science and technology.
2023-12-20 13:47 -
Advancing the Fight Against Lung Cancer: Promising Breakthroughs in Targeted Therapies
In the relentless pursuit to conquer lung cancer, global pharmaceutical companies are dedicated to developing the fourth-generation EGFR inhibitors.
2023-12-19 14:20
Hot News
- SABIC Shuts Down 865,000-Ton U... Jul 02, 2025
- ExxonMobil Launches $10 Billio... Jul 17, 2025
- The Truth Behind the US-China ... Jun 30, 2025
- Sally Beauty Acquires Flair Ha... Jul 07, 2025
- UBE Corporation Accelerates Ch... Jul 02, 2025
Related Products
Related Producers
